South korea launches real-world safety check on bladder cancer drug PADCEV
NCT ID NCT06011954
First seen Oct 01, 2025 · Last updated May 24, 2026 · Updated 31 times
Summary
This study is observing about 200 adults in South Korea with advanced bladder cancer who are already prescribed PADCEV. Researchers will track side effects and how well the cancer responds over about one year. No new treatments are given—only medical records are reviewed.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for UROTHELIAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Site KR82001
RECRUITINGGoyang-si, Gyeonggi-do, 10408, South Korea
-
Site KR82002
RECRUITINGSeoul, 02841, South Korea
-
Site KR82003
ACTIVE_NOT_RECRUITINGSeoul, 03722, South Korea
-
Site KR82004
ACTIVE_NOT_RECRUITINGIncheon, 21565, South Korea
-
Site KR82005
RECRUITINGSeoul, 03181, South Korea
-
Site KR82006
RECRUITINGSeoul, 07417, South Korea
-
Site KR82007
COMPLETEDJeollanam-do, Jeollanam-do, 58128, South Korea
-
Site KR82008
RECRUITINGSuwon, Gyeonggi-do, 16500, South Korea
-
Site KR82009
ACTIVE_NOT_RECRUITINGBusan, 49201, South Korea
-
Site KR82010
COMPLETEDBusan, 48108, South Korea
-
Site KR82011
RECRUITINGSeoul, 07985, South Korea
-
Site KR82012
RECRUITINGSuwon, Gyeonggi-do, 16247, South Korea
-
Site KR82013
RECRUITINGJeonju, Jeonbuk-do, 54907, South Korea
-
Site KR82014
RECRUITINGDaegu, 42415, South Korea
-
Site KR82015
ACTIVE_NOT_RECRUITINGBusan, 47392, South Korea
-
Site KR82016
COMPLETEDBusan, 50612, South Korea
-
Site KR82017
ACTIVE_NOT_RECRUITINGSeoul, 06351, South Korea
-
Site KR82018
RECRUITINGDaejeon, 35365, South Korea
Conditions
Explore the condition pages connected to this study.